1. Home
  2. MHH vs IMA Comparison

MHH vs IMA Comparison

Compare MHH & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mastech Digital Inc

MHH

Mastech Digital Inc

N/A

Current Price

$6.34

Market Cap

78.2M

ML Signal

N/A

IMA

ImageneBio Inc.

N/A

Current Price

$3.65

Market Cap

66.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MHH
IMA
Founded
1986
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.2M
66.3M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
MHH
IMA
Price
$6.34
$3.65
Analyst Decision
Buy
Analyst Count
0
4
Target Price
$12.75
★ $18.00
AVG Volume (30 Days)
7.0K
★ 9.4K
Earning Date
10-30-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.01
N/A
Revenue
★ $191,371,000.00
$800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.94
N/A
P/E Ratio
$627.00
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.50
$3.34
52 Week High
$8.37
$7.89

Technical Indicators

Market Signals
Indicator
MHH
IMA
Relative Strength Index (RSI) 43.26 23.89
Support Level $6.24 N/A
Resistance Level $6.84 $6.13
Average True Range (ATR) 0.32 0.24
MACD 0.03 -0.04
Stochastic Oscillator 10.35 5.55

Price Performance

Historical Comparison
MHH
IMA

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. The IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

About IMA ImageneBio Inc.

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Share on Social Networks: